Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 6, 2012, Pages 897-905

  Zhao, Bowen ^a   Li, Bin ^a,c   Bai, Shuwei ^a   Shen, Ling ^a   Ren, Ruojin ^a   Jonas, Jost B ^b   Xu, Xiaolin ^a   Lu, Qingjun ^a   Liu, Qian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c BEIJING INSTITUTE OF OPHTHALMOLOGY   (China)

Author keywords

Apoptosis; Cell proliferation; Matrine; Retinoblastoma; Traditional Chinese medicine

Indexed keywords

CYCLIN D1; MATRINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MITOSIS INHIBITION; NICK END LABELING; PRIORITY JOURNAL; WESTERN BLOTTING;

ALKALOIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON, TRANSMISSION; MITOSIS; QUINOLIZINES; RETINAL NEOPLASMS; RETINOBLASTOMA; TUMOR CELLS, CULTURED;

EID: 84864297885     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1751-4     Document Type: Article

References (34)

1. Kyogoku K, Hatayama K, Komatsu M (1973) Constituents of Chinese crude drug "Kushen" (the root of Sophora flavescens Ait.). Isolation of five new flavonoids and formononetin. Chem Pharm Bull 21:2733-2738
2. Han J, Sun MY, Cui YM (2007) Kushen flavonoids induce apoptosis in tumor cells by inhibition of NF-kappaB activation and multiple receptor tyrosine kinase activities. Phytother Res 21:262-268 (Pubitemid 46479678)
3. Sun MY, Zuo J, Duan JF, Han J, Fan SM, Zhang W, Zhu LF, Yao MH (2008) Antitumor activities of kushen flavonoids in vivo and in vitro. Zhong Xi Yi Jie He Xue Bao 6:51-59 (Pubitemid 351166466)
4. Zhang Y, Zhang P, Cheng Y (2008) Structural characterization of isoprenylated flavonoids from Kushen by electrospray ionization multistage tandemmass spectrometry. J Mass Spectrom 43:1421-1431
5. Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS, Xu XR, Liu BZ, He YJ (2001) Effect of matrine on proliferation and differentiation in K-562 cells. Leuk Res 25:793-800 (Pubitemid 32734092)
6. Wan XY, Luo M, Li XD, He P (2009) Hepatoprotective and antihepatocarcinogenic effects of glycyrrhizin and matrine. Chem Biol Interact 181:15-19
7. Liu XS, Jiang J (2006) Molecular mechanism of matrine-induced apoptosis in leukemia K562 cells. Am J Chin Med 34:1095-1103 (Pubitemid 44921253)
8. Wu CX, Chen YH, Zheng ZX (2006) Observation on efficacy of matrine with dansheng on liver fibrosis. J Pract Med (Shi Yong Yi Xue Za Zhi) 22:1567-1568
9. Yu W, Li B, Ren RJ, Gao F, Li LQ, Liu XC, Wang Y (2006) The effects of matrine on cell proliferation and telomerase activity in retinoblastoma cells in vitro. Zhonghua Yan Ke Za Zhi [Chinese Journal of Ophthalmology] 42:594-599 (Pubitemid 44382811)
10. Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q, Li J, Pang L, Chen K, Qiu F, Yu X, Yang J, Huang J (2007) Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology 229:245-252 (Pubitemid 44937494)
11. Liu JY, Hu JH, Zhu QG, Li FQ, Wang J, Sun HJ (2007) Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. Int Immunopharmacol 7:816-823 (Pubitemid 46635279)
12. Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J (2008) Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol 8:1767-1772
13. Liu XY, Fang H, Yang ZG, Wang XY, Ruan LM, Fang DR, Ding YG, Wang YN, Zhang Y, Jiang XL, Chen HC (2008) Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. Int J Dermatol 47:448-456 (Pubitemid 351560308)
14. Jung E, Lee J, Huh S, Lee J, Hwang H, Kim Y, Kim YW, Byun SY, Park D (2008) Matrine inhibits PMA-induced MMP-1 expression in human dermal fibroblasts. Biofactors 33:121-128
15. Xu X, Ling Q, Gao F, He ZL, Xie HY, Zheng SS (2009) Hepatoprotective effects of marine and kuhuang in liver transplant recipients. Am J Chin Med 37:27-34
16. Zhang S, Qi J, Sun L, Cheng B, Pan S, Zhou M, Sun X (2009) Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Mol Biol Rep 36:791-799
17. Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan H, Luan G, Yagasaki K, Zhang G (2009) Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 59:191-200
18. Qin XG, Hua Z, Shuang W, Wang YH, Cui YD (2010) Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro. Pharm Biol 48:275-281
19. Zheng MQ, Pan WN, Zhu YQ (2003) Pharmacodynamic studies on matrine eye drops for experimental ocular inflammation in rabbits. Zhong Yao Xin Yao Yu Lin Chuang Yao Li [Traditional Chinese Drug Research & Clinical Pharmacology] 14:109-111
20. Luo K, Wan XG, Deng JY, Liu F (2010) Clinical observation on the therapeutic efficacy of matrine with autologous stem cell transplantation in treatment of pterygium. Shi Yong Lin Chuang Yi Xue [Practical Chinese Medicine] 11:77-78
21. Liu DY, Ma JX, An JB, Wang M (2009) Preventive effect of matrine polyactic acid microsphere on proliferative vitreoretinopathy. Chin Ophthal Res (Yan Ke Yan Jiu) 27:950-954
22. Liu DY, Ma JX, Cao DY, Wang JX, Liu JZ, Lv LC (2010) Sustained release ability and safety of matrine polyactic acid microsphere intravitreal injection. Chin Ophthal Res (Yan Ke Yan Jiu) 28:34-38
23. Shields CL, Shields JA (2006) Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17:228-234 (Pubitemid 44309745)
24. Wang Y, Lin CH, Xiao RP (2010) Effect of closed thoracic drainage with central venous catheters and combining cis-platinum(DDP)with matrine to pure into the thoracic cavity with malignant pleural effusion. Hai Nan Yi Xue [Hainan Medical Journal] 21:13-15
25. Cui DG, Li SY, Wang SY (2007) Clinical evaluation if interferon a1b associated with matrine in the treatment of liver fibrosis in hepatitis B. Zhong Guo Xin Yao Za Zhi [Chinese Journal of New Drugs] 16:314-316
26. Wan NY, Su ZW (2009) United adefovtr dipivoxil and matrine treatment efficacy analysis of hepatitis B. Si Chuan Yi Xue [Si Chuan Medical Journal] 30:930-932
27. Xie DY, Yuan ZD, Lin GJ, Peng SL (2008) Observation of curative effect of matrine injection on infant cytomegalovirus hepatitis. Shi Yong Er Ke Lin Chuang Za Zhi [Journal of Applied Clinical Pediatrics] 23:524-526
28. Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu EW, Tralka TS, Wilcox JL (1974) Characteristics of an established cell line of retinoblastoma. Cancer Inst 53:347-360
29. to here McFall RC, Sery TW, Makadon M (1977) Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 37:1003-1010 (Pubitemid 8088167)
30. Jie J, Yuzhen Y, Jianliang Z, Guanguang F, Ruling Z (1991) Establishment and characterization of a human retinoblastoma cell line SO-RB50. Zhong Shan Yi Ke Da Xue Xue Bao [Journal of Sun Yat-sen University] 12:173-177
31. Oltvai ZN, Milliman CM, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619 (Pubitemid 23259742)
32. Knudson CM, Tung KS, Tourtellotte WG (1995) Bax-deficient mice with lymphoid hyperplasis and male germ cell death. Science 270:96-99
33. Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T (1994) Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9:323-326 (Pubitemid 24020966)
34. Bukholm IK, Nesland JM (2000) Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 436:224-228 (Pubitemid 30168680)